Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression.

J Clin Oncol · 2024 · PMC11107894 · PMID 38422473

Europe PMC DOI

hedged sentences

0.0400

closest p · 0.8× alpha

0.0540

boldest claim

The sentences

marginally significantP = .04actually significant

Interaction between treatment and continuous Trop-2 expression for OS was marginally significant (range, P = .04 to 0.05); interaction between treatment and Trop-2 H-score quartiles for OS was trending toward significance ( P = .054; Data Supplement, Table S5).

also in 3,399 other papers

trending toward significanceP = .054so close (0.05 < p ≤ 0.1)

Interaction between treatment and continuous Trop-2 expression for OS was marginally significant (range, P = .04 to 0.05); interaction between treatment and Trop-2 H-score quartiles for OS was trending toward significance ( P = .054; Data Supplement, Table S5).

also in 100 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.